Company: ZDAN
Filing Date: 2025-01-10
Form Type: DRS/A
Source: 0001683168-25-000168
Chunk: 109

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-01-10
Form: DRS/A
Chunk 109
---
 |
| · | strategic actions by our competitors;                                     |
| · | changes in revenue or earnings estimates, or changes in recommendations   
 or withdrawal of research coverage, by equity research analysts;          |
| · | speculation in the press or investment community;                         |

| 57 |

| · | the failure of research analysts to cover our Ordinary Shares;              |
| · | sales of our Ordinary Shares by us or other shareholders, or the perception 
 that such sales may occur;                                                  |
| · | changes in accounting principles, policies, guidance, interpretations       
 or standards;                                                               |
| · | additions or departures of key management personnel;                        |
| · | actions by our shareholders;                                                |
| · | domestic and international economic, legal and regulatory factors unrelated 
 to our performance; and                                                     |
| · | the realization of any risks described under this “Risk Factors”            
 section.                                                                    |

The stock markets in general
have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. These broad market
fluctuations may adversely affect the trading price of our Ordinary Shares. Securities class action litigation has often been instituted
against companies following periods of volatility in the overall market and in the market price of a company’s securities. Such
litigation, if instituted against us, could result in very substantial costs, divert our management’s attention and resources and
harm our business, operating results and financial condition.

Our Ordinary Shares have never been publicly traded, and, as such, the price of our Ordinary Shares may fluctuate substantially.

Before this initial public
offering, there was no public market for our Ordinary Shares. The initial public offering price for our Ordinary Shares will be determined
through negotiations between the Underwriter and us and may vary substantially from the market price of our Ordinary Shares following
this offering. An active public trading market may not develop after completion of this offering or, if developed, may not be sustained.
The lack of an active market may impair your ability to sell your shares at the time you wish to sell them or at a price that you consider
reasonable. An inactive market may also impair our ability to raise capital by selling shares and may impair our ability to acquire other
products, technologies or businesses using our Ordinary Shares as consideration. Furthermore, if our Ordinary Shares are approved for
listing on Nasdaq, there can be no guarantee that we will continue to satisfy the continued listing standards of Nasdaq. If we fail to
satisfy the continued listing standards, we could be